✦ LIBER ✦

Once-daily ropinirole reduces 'off' time in Parkinson's disease

Book ID: 120848326
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715820-00043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of once-daily versus twice-da

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

✍ Yun, Ji; Kim, Han-Joon; Lee, Jee-Young; Kim, Young; Kim, Ji; Kim, Jong-Min; Jeon 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 285 KB

P2.166 Once-daily ropinirole prolonged r

P2.166 Once-daily ropinirole prolonged release improves activities of daily living and motor symptoms in patients with advanced Parkinson's disease

✍ F. Stocchi; L. Giorgi; K. Rolfe; C.B. Rockett 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P2.165 Dose-related decrease in “off” ti

✍ F. Stocchi; B. Hunter; L. Giorgi; R.A. Hauser 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB

P2.164 Ropinirole prolonged release main

P2.164 Ropinirole prolonged release maintains an increase in daily awake time spent “on” in patients with advanced Parkinson's disease

✍ F. Stocchi; B. Hunter; L. Giorgi; B. Hersh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Patient-reported convenience of once-dai

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease

✍ A. H. V. Schapira; P. Barone; R. A. Hauser; Y. Mizuno; O. Rascol; M. Busse; C. D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

Randomized, double-blind, multicenter ev

Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

✍ Robert A. Hauser; Anthony H.V. Schapira; Olivier Rascol; Paolo Barone; Yoshikuni 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 1 views

## Abstract The objective of this study was to evaluate the efficacy and safety of pramipexole extended release (ER) administered once daily in early Parkinson's disease (PD). Pramipexole immediate release (IR) administered three times daily (TID) is an efficacious and generally well‐tolerated trea